Market
why Corcept Therapeutics Inc [CORT] is a Good Choice for Investors After New Price Target of $36.83
Corcept Therapeutics Inc [NASDAQ: CORT] traded at a high on Thursday, posting a 2.51 gain after which it closed the day’ session at $21.63. The company report on January 29, 2024 at 8:00 AM that Corcept Appoints Roberto Vieira as President, Oncology. Mr. Vieira joins
